|
|
Article: Endocardial Solutions, Inc. Reports First Quarter Results
- Article from:
- PR Newswire
- Article date:
- April 30, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ST. PAUL, Minn., April 30 /PRNewswire/ -- Endocardial Solutions, Inc. (Nasdaq: ECSI), a company engaged in the development of diagnostic products for the electrophysiology market, today reported financial results for the first quarter ended March 31, 1997. Net loss for the first quarter was $1,865,264, or $0.31 per share, compared with a net loss of $1,271,952, or $0.25 per share for the same period in 1996.
"We are pleased to be reporting for the first time as a public company," said Jim Bullock, President and CEO. "A key milestone during the first quarter was the continued expansion of our clinical trial experience. To date, we have completed 36 human ...
Related newspaper, magazine, and journal articles:
|
|
Article: Endocardial Solutions Announces Third Quarter ...
PR Newswire;
October 20, 1999 ;
700+ words
... ... PRNewswire/ -- Endocardial Solutions, Inc. (Nasdaq ... of 1998. The net loss for the third ... operations of Endocardial Solutions. Endocardial Solutions, Inc. Consolidated ... 721 167,738 Net loss for the period ...
|
|